M. I. V. (1976). Annals of the Rheumatic Diseases, 35, 138-142. Thrombocytosis in rheumatoid arthritis. Of 75 patients with rheumatoid arthritis, 39 had a thrombocytosis and 36 a normal platelet count. A highly significant relationship existed between the platelet count and disease severity and an inverse correlation with level of haemoglobin. An association appeared to exist between thrombocytosis and extra-articular manifestations of rheumatoid disease. By "Selenomethionine labelling platelet and fibrinogen survival and turnover were determined. In 3 rheumatoid patients with thrombocytosis platelet survival was decreased and turnover increased. In these and a further rheumatoid patient with a normal platelet count there was reduced fibrinogen survival and increased fibrinogen turnover, and in addition excess fibrin degradation products were detected. The results suggest that thrombocytosis accompanies the more severe cases of rheumatoid disease and is due to a compensatory increase in platelet production associated with active intravascular coagulation.
In a wide series of observations platelet counts in Methods and materials healthy individuals lie within the range 150-450 x 109/l (150 000-450000/mm3). Selroos (1972) Seventy-five patients with classical or definite RA (Ropes, noted raised platelet counts in one-third of patients and others, 1959) were studied and comparisons were with rheumatoid arthritis (RA) and a direct re-drawn between those with normal and those with raised watitnshirheu toinathritiso (RA) d and diretre-platelet counts. The activity and severity of disease were lationship betwlsoobserven throm ctoise and disteleaoutse assessed by duration of involvement, presence of extraactivity. He also observed that raised platelet counts articular manifestations, morning stiffness, grip strength, correlated with anaemia, sideropenia, leucocytosis, and joint score. Patients were then graded as inactive 0, and rheumatoid factor. A possible relationship to mildly active 1, active 2, and very active 3. Drug therapy amyloid was investigated but discounted later at the time of the platelet count was noted. (Selroos and Pettersson, 1973a) .
Peripheral blood haemoglobin, white cell count and We have similarly noted thrombocytosis in patients differential were estimated by conventional methods.
with severe RA. Platelet counts in some were Platelets were counted by a Coulter thrombocytometer.
> 1000 x 109/l (1 million/mm3), falling to normal in Standard data and control information from our laborasome cae hnth ieswscnrlldb r tory suggest the upper limit of normal to be 450 x 109 some cases when the disease was controlled by drug platelets/1(450000/mm3). Plasma viscosity was determined therapy. However, in one case thrombocytosis instead of the erythrocyte sedimentation rate as it is appeared on starting gold therapy, while in another independent of the haematocrit. Serological investigations thrombocytosis developed on starting penicillamine included rheumatoid factor by Rose-Waaler and latex treatment. techniques, and antinuclear antibodies. Serum immunoThis study attempts to assess the significance of globulins and complement levels were estimated in some thrombocytosis in RA, and determine whether cases. As blood loss from the intestine is common among platelet counts correlate with parameters of disease patients treated with anti-inflammatory drugs, the stools activity. Particular (Brodsky and others, 1970, 1972a, b) . Surface counting was conducted over the heart, spleen, liver, sacrum, and clinically active and quiescent joints.
HAEMATOLOGY AND SEVERITY OF DISEASE Table II . Cutaneous vasculitis showed a significant relationship with thrombocytosis (P < 0-05). In none cf the 36 patients with a normal platelet count were lymphadenopathy, pulmonary interstitial fibrosis, Sj0gren's syndrome, or peripheral neuropathy found. When present the platelet count was raised but the numbers of cases were too small to draw statistical conclusions. Though nodules were more common in the patients with high platelet counts, the association was not significant (P > 0-05).
Serological data are given in Table Ill . The mean plasma viscosity was significantly increased in the -patients with thrombocytosis (P < 0-01). Titres of rheumatoid factor of 1: 64 or greater occurred more often in those with thrombocytosis, and all 5 patients with a positive antinuclear factor fell in this group. There were insufficient numbers to draw any conclusions as regards complement activation, though depressed levels were found in some of those with raised platelet counts.
Although more patients with thrombocytosis had low serum iron levels, the difference was not statistically significant (Table IV) . Six patients had persistently strongly positive occult bloods, but in only one of these was the platelet count raised above normal.
TREATMENT AND PLATELET COUNT Expressed as a percentage of 75 patients, the following drugs were used: aspirin (23 %), phenylbutazone (6-6%/), indomethacin (44%), gold (59 %), D-penicillamine (22-5 %), steroids (41-5 %).
There was no meaningful relation between therapy and thrombocytosis. Aspirin ingestion did not correlate with raised platelet counts. This drug specifically inhibits the release of adenosine diphosphate from within the platelet, and thus blocks secondary aggregation (Evans and others, 1968) . It would thus prevent platelet thrombus formation rather than enhance it. Penicillamine and steroids were prescribed more frequently in patients with thrombo- cytosis than in those without, but these subjects usually had more active disease. In 3 patients with extra-articular manifestations and thrombocytosis, high-dose prednisone therapy produced a fall in platelet counts to normal at the same time as remissions of disease activity.
RADIOISOTOPE STUDIES
The results are shown in Table V and are compared with normal data obtained by ourselves and others elsewhere (Brodsky and others, 1970, 1972a, b) . In the 3 patients with thrombocytosis there was a reduced platelet survival and a raised platelet turnover. Serum fibrinogens were raised and there were excess fibrin degradation products, reduced fibrinogen survivals, and increased fibrinogen turnovers, most marked in the patient with the highest platelet count. Even the rheumatoid patient with a normal platelet count showed some evidence of increased fibrinogen turnover. In 2 of the 3 patients with thrombocytosis there was a persistent increase in uptake of 7'Selenomethionine in active joints relative to quiescent joints, but it was impossible to ascertain whether this was due to platelet or fibrin deposition or both.
Discussion
Our results confirm that thrombocytosis is often seen in patients with active RA, and that the height of the platelet count correlates directly with the degree of disease activity and inversely with the haemoglobin level. No significant relationship between thrombocytosis and sideropenia was found. Plasma viscosity was significantly higher in those patients with thrombocytosis. A significant correlation existed between thrombocytosis and cutaneous vasculitis, and other extra-articular manifestations of rheumatoid disease were more common in those with a raised platelet count. Further evidence that thrombocytosis is related to disease activity was seen in 3 patients by a fall in platelet levels to normal when the disease was suppressed by steroid therapy. There are several possible explanations for these changes in platelet count. Thrombocytosis is a feature of both acute and chronic blood loss and in RA could be due to the chronic anaemia characteristic of active disease (Mowat and Hothersall, 1968) . Although an inverse correlation was found between high platelet counts and low haemoglobin, thrombocytosis was not associated with gastrointestinal blood loss. However, Choie Sun, Simone, and Jackson (1974) have shown that both chronic anaemia and iron deprivation of the normoblast may play some part in the production of thrombocytosis. Platelet homoeostasis is controlled by a humoral regulatory factor, thrombopoietin, which influences megakaryocyte size, ploidy, number, and maturation rate (Ebbe, 1974) . It is thought that thrombopoietin may be related chemically to erythropoietin as chronically anaemic patients with persistent reticulocytosis and increased erythropoietin levels have higher than normal platelet counts (Pitney, 1972) . Similarly, if erythropoietin levels are increased in anaemic rheumatoid patients, then thrombocytosis could result.
Alternatively, increased platelet production may be induced by increased platelet destruction or consumption. Garg Although the aetiology of RA is unknown, studies on its pathogenesis suggest that it is an extravascular immune complex disease (Zvaifler, 1974) . Thrombocytosis may be related to the immunological responses in RA, being secondary to microthromboses within the chronically inflamed rheumatoid synovium. 
